Carbon-ion radiotherapy facilities using next generation technologies

Dr Kamada meets with ecancertv at Proton Therapy Congress 2016 to discuss carbon-ion beams, which he considers an alternative to proton therapy.
While the cost of carbon-ion beam installation is high, he describes how the options of hypofractionation offer patient benefits and clinical flexibility to handle a large number of patients.
Prof Kamada also rates the higher outcomes of patients with advanced sarcoma, which might otherwise be unresectable nor susceptible to proton beam therapy.
With dose escalation established, Prof Kamada considers a future for identifying radioresistance to carbon therapy to improve cure rates, and secure a place for it in treatment of cancer.